Haofan Biological: Employee strategic placement asset management plan to reduce their holdings by no more than 0.50% of shares.

Haofan Biotechnology announcement, shareholder Minsheng Securities - CITIC Bank - Minsheng Securities Haofan Biotechnology Strategic Placement No. 1 Collective Asset Management Plan holds 541,800 shares, accounting for 0.50%. It is planned to reduce no more than 541,800 shares, accounting for 0.50% of the total share capital of the company, through centralized bidding or block trading within 3 months after the announcement disclosure date and 15 trading days later. The source of the shares is the strategic placement of senior executives and employees in the initial public offering.